Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
Edouard L. Fu, Rishi Desai, Julie M. Paik, Dae Hyun Kim, Yichi Zhang, Julianna Mastrorilli, Alexander Cervone, Kueiyu Joshua Lin
Topics & Concepts
MedicineRivaroxabanApixabanAtrial fibrillationWarfarinInternal medicineCohortCardiologyCohort studyIntensive care medicineAtrial Fibrillation Management and OutcomesAcute Kidney Injury ResearchIntracerebral and Subarachnoid Hemorrhage Research